Skip to main content
WBF What is
brain fog?
Support WBF Take quiz

Test guide Blood test

Cystatin C Blood Test and Brain Fog

Creatinine and cystatin C can give different eGFR results. Low muscle mass can make creatinine less reliable. Thyroid disease, inflammation, steroid treatment, pregnancy, and other health factors can shift cystatin C. Compare both markers and the medical context before choosing which estimate to use.

A blood marker used to estimate GFR The laboratory measures cystatin C in blood and can calculate an eGFR from it. The raw protein level is not a kidney stage. Two markers often estimate better than one Creatinine and cystatin C have different errors. A combined equation is often the most accurate estimate when a decision depends on GFR. Less muscle effect does not mean no outside effect Steroids, thyroid dysfunction, inflammation, and body fat can change cystatin C apart from kidney filtration.
01

Why cystatin C helps most when it answers a specific uncertainty.

The same blood draw may give two eGFR results: one from creatinine and one from cystatin C. Different results do not mean the lab failed. One marker may fit your body better than the other.

When muscle mass makes creatinine less reliable

A second blood marker can check an estimate distorted by muscle.

Low muscle, frailty, amputation, paralysis, malnutrition, or unusually high muscle can make creatinine-based eGFR fit poorly. Cystatin C offers a different marker.

Compare creatinine and cystatin C

The two-marker result usually matters more than choosing one result over the other.

When both markers are usable, eGFRcr-cys can reduce the separate errors. A large disagreement still deserves an explanation.

When kidney problems may affect thinking

The test checks filtration, not the source of brain fog.

Thinking problems are more common as kidney disease advances, but cystatin C can't show that the kidneys caused one person's thinking problems.

What cystatin C cannot answer.

Cystatin C is one part of a kidney assessment. Use urine ACR, changes over time, symptoms, and medical review to diagnose kidney disease, find the cause, and set medicine doses. Pregnancy needs its own kidney assessment.

Save this test

Save both kidney estimates, earlier results, and what needs follow-up

Keep the original laboratory report. Bring a short summary with both blood markers, every reported estimate, and urine ACR. Add what was happening around the sample, your symptoms, and the question you need answered.

02

How do age, growth, pregnancy, frailty, steroids, thyroid status, inflammation, body composition, and illness affect cystatin C?

Cystatin C avoids some muscle-related error, but age, growth, pregnancy, illness, body context, and the equation still matter. The correct interpretation changes across the life course.

Newborns and young babies

The marker is naturally higher in newborns because kidney filtration is still maturing. Mayo notes higher levels in babies younger than 3 months, and pediatric laboratory intervals can change quickly across the first year. Use gestational age, postnatal age, illness, feeding, urine output, and a newborn or child kidney equation, not an adult cutoff.

Children and teenagers

Adult CKD-EPI equations do not apply. A pediatric equation may use the marker by itself or combine it with creatinine, age, sex, height, or other variables. Growth, puberty, congenital kidney or urinary disease, muscle conditions, inflammation, steroid treatment, thyroid status, blood pressure, and urine results belong beside the number.

Young adults ages 18 to 25

A result can shift when a service switches from a pediatric equation to an adult equation. NIDDK says CKiD U25 equations can maintain a steadier trend for some 18-to-25-year-olds with mild-to-moderate CKD. Save the equation name with each result so a birthday is not mistaken for a kidney change.

Pregnancy and after birth

Cystatin C does not rescue standard eGFR during pregnancy. Gestational changes can raise the marker apart from filtration, and kidney function can change quickly around birth. Use the pregnancy week or days after birth, serum creatinine, blood pressure, urine protein, symptoms, and maternity or kidney-team assessment.

Older adults, frailty, and muscle loss

This blood marker can help when low muscle mass makes creatinine-based eGFR look too reassuring. A 2024 study included 5,574 adults aged 65 and older. In 30%, eGFRcys was more than 30% lower than eGFRcr. Large differences became more common with age. Frailty, inflammation, body fat, smoking, thyroid disease, and steroid use can still affect the comparison.

03

Before the appointment, keep your routine ordinary and bring the details that can shift either kidney marker.

Ask whether the clinician wants cystatin C alone, with creatinine, or in the combined eGFR calculation. Cystatin C usually needs no special preparation. Follow any rules for other tests done at the same visit.

Eat, drink, and move as usual unless you have other instructions. Do not force water, dehydrate yourself, stop protein, or do a hard workout to change the result.

Bring a list or photos of all medicine, injections, inhalers, creams, supplements, and bodybuilding products. Include every steroid. Do not stop a steroid, thyroid medicine, or other prescription unless the prescriber tells you to.

Record thyroid changes, fever, infection, inflammation, cancer care, a hospital stay, large weight changes, pregnancy, and recent birth. Bring older creatinine, cystatin C, eGFR, and urine ACR results.

01

The blood sample

A clinician draws a small tube of blood from a vein. The lab measures cystatin C and may report an eGFR based on it, called eGFRcys.

02

Compare cystatin C with creatinine

Keep cystatin C, its unit and lab range, eGFRcys, creatinine, eGFRcr, and combined eGFRcr-cys together. Add urine ACR, the date, medicine, illness, thyroid and steroid use, and older kidney results.

04

How to read cystatin C when the portal shows more than one kidney estimate.

Start with the raw value, unit, interval, eGFRcys, creatinine, eGFRcr, and combined eGFRcr-cys. Then add urine albumin (ACR), earlier results, steroids, thyroid and inflammatory illness, pregnancy, smoking, body changes, medicines, and the reason for the test.

Inside the interval and estimates agree

Inside the reporting interval with broadly agreeing kidney estimates

This is more reassuring when the creatinine and combined eGFR, urine ACR, blood pressure, older results, and reason for testing also fit. Early kidney damage or another cause of brain fog may still be present.

High cystatin C or lower eGFRcys

Above the reporting interval or a lower cystatin C-based eGFR

The kidneys may be filtering less well. Compare creatinine, combined eGFR, urine ACR, older results, and symptoms. Also review steroids, thyroid health, inflammation, body changes, smoking, illness, and the lab method.

Low cystatin C or higher eGFRcys

Below the interval or a higher cystatin C-based eGFR

Low cystatin C often gives a higher eGFRcys. This doesn't prove the kidneys work better than usual. Check the lab note, the equation for your age, test limits, creatinine, and urine results.

The two estimates differ substantially

Cystatin C and creatinine estimates differ substantially

The difference may show that something is changing one marker. Use the combined eGFR when it fits. A measured GFR may help when both markers are unreliable and an exact result would change treatment.

A large difference is not permission to choose the nicer number.

Use the two-marker equation when appropriate and ask what could affect each blood result. Take extra care when the result is close to a medicine or procedure cutoff. If both markers may be unreliable or the person is very unwell, measured GFR or prompt medical care may matter more than another web calculator.

See research details

Interpret cystatin C separately from eGFR, distinguish muscle-related from cystatin-related error, and do not treat an association with chronic disease as proof of a brain-fog cause.

SourceCystatin C is a marker, not the final kidney answer ContextCells produce cystatin C and healthy kidneys filter it. The blood concentration usually rises as filtration falls. Laboratories use the value in an equation to report eGFRcys, which is still an estimate rather than a direct measurement of GFR.

Keep the raw value and the calculated estimate together. Read the eGFR with its equation, unit, laboratory interval, earlier results, and urine ACR instead of treating cystatin C as a stand-alone diagnosis.

SourceThe combined estimate may be more accurate ContextCreatinine and cystatin C have different sources of error. KDIGO and NIDDK favor the combined creatinine-cystatin C equation when creatinine may be inaccurate and the GFR result affects an important decision.

Ask for the combined eGFRcr-cys. Comparing two raw values by eye isn't enough. If a strong outside influence affects one marker, the clinician may use the other marker or measured GFR instead of assuming combination always fixes the problem.

SourceCystatin C has its own outside influences ContextNIDDK lists steroid use, thyroid dysfunction, adiposity, and inflammation as factors that can raise cystatin C apart from GFR. NKF also warns about untreated thyroid disease and steroid treatment. Smoking and other illness context can matter too.

Record the medicine, dose timing if known, thyroid status, inflammatory or acute illness, smoking, and major body change. Stay on treatment and take a high result seriously. Ask whether the context favors a combined estimate, repeat, or measured GFR.

SourceA large marker difference is common enough to plan for ContextA 2025 individual-level meta-analysis included 821,327 outpatients and 39,639 inpatients. Cystatin C-based eGFR was at least 30% lower than creatinine-based eGFR in 11% of outpatients and 35% of inpatients. That pattern was associated with worse outcomes but did not prove a cause.

Do not choose the higher estimate for reassurance or the lower one for certainty. Find possible influences on each marker, calculate eGFRcr-cys, and decide whether a direct measurement would change a medicine, procedure, transplant, donation, or other high-stakes decision.

SourceThe difference cannot be reduced to muscle alone ContextA 2025 CRIC analysis studied 1,290 adults with CKD and directly measured GFR. Muscle, larger-molecule clearance, obesity, inflammation, and other proposed factors explained only 36% of the difference between the two estimates. The study could not identify one simple cause for every mismatch.

Look at muscle and frailty, but they won't explain everything. Preserve both results and the measured context so the clinician can decide whether the gap reflects marker biology, health status, filtration, or more than one factor.

SourceCKD still needs time or another damage marker ContextA low eGFRcys does not make one blood draw a chronic diagnosis. KDIGO defines chronicity as at least 3 months. Urine albumin, blood or other urine abnormalities, imaging, inherited disease, or transplant history can show kidney damage even when filtration is preserved.

Compare with older results and put urine ACR or urinalysis beside the estimate. If the change may be acute, the repeat and safety assessment can be sooner than 3 months. Seek care as soon as serious symptoms worsen.

SourceAcute illness can change both filtration and the marker ContextCystatin C may respond faster than creatinine when kidney function changes, but critical illness, inflammation, steroids, fluid shifts, and non-steady kidney function can also complicate interpretation. It does not replace the acute kidney injury assessment.

Use the illness timeline, urine output, creatinine trend, electrolytes, medicines, fluid balance, and clinical examination. A sharply reduced estimate with little urine, breathing trouble, confusion, repeated vomiting, or rapidly worsening illness needs timely assessment.

SourcePregnancy changes cystatin C outside filtration ContextUK kidney guidance says standard eGFR is not valid during pregnancy. Cystatin C can rise in the second trimester despite pregnancy-related changes in GFR, which means gestational factors alter the marker and prevent its routine use as a substitute.

Use the pregnancy week or days after birth, serum creatinine, blood pressure, urine protein, symptoms, and the maternity team's plan. Do not use a portal eGFRcys to stage or reassure a pregnant person.

SourceThere is no cystatin C brain-fog threshold ContextA 2026 cohort of 5,607 people with CKD associated lower filtration and more urine protein with higher incidence of selected cognitive impairments. A 2025 review says much of the CKD cognition evidence remains cross-sectional or associative and cannot prove cause for one person.

Ask whether thinking changes fit with kidney severity, urine protein, anemia, blood pressure, diabetes, sleep, medicines, blood vessel risk, and timing.

05

What you can do without trying to lower cystatin C yourself.

Do not try to force one cystatin C value down. Keep the details needed to read the result, find the cause, and protect kidney health when a risk is confirmed.

Keep both markers and sample details together

Save cystatin C, creatinine, every eGFR, urine ACR, the lab, and the date. Add steroids, thyroid changes, infection, inflammation, a hospital stay, smoking, body changes, pregnancy, and medicine.

Protect against the risks you have

If kidney disease or risk is confirmed, follow your blood pressure and diabetes plans. Take prescribed kidney medicine, stop smoking, move and sleep as advised, and choose food that fits your kidney health. A kidney dietitian can help without cutting protein, potassium, salt, or fluid from one result.

Review medicines before changing or adding anything

Ask a clinician or pharmacist about pain medicine, cold remedies, herbs, creatine, bodybuilding products, and supplements when kidney function is unclear. List all steroids. Do not stop a steroid or change thyroid or kidney medicine from this result.

Protect kidney health, but let the paired results and confirmed cause decide treatment.

Food, movement, sleep, quitting smoking, and care for known risks can protect health over time. Kidney filtration still needs blood and urine tests. A doctor must treat a urinary blockage or sudden kidney injury and set medicine doses. Steroids, thyroid disease, inflammation, and pregnancy can also alter cystatin C. A critical result, sharply reduced urine, trouble breathing, repeated vomiting, new confusion, or rapidly worsening illness needs medical assessment.

06

Bring both markers, the urine result, and what was happening that week.

Keep these together

  • Cystatin C result, unit, printed interval, date, assay or laboratory comment, and eGFRcys equation if shown.
  • Creatinine, eGFRcr, two-marker eGFRcr-cys, urine ACR or urinalysis, and the most comparable earlier kidney results.
  • Steroid tablets, injections, inhalers or creams, thyroid diagnosis and treatment, infection, inflammation, cancer treatment, hospitalization, smoking, and major weight or muscle change.
  • Blood pressure, diabetes results, medicines and supplements, pregnancy or postpartum timing, urine changes, swelling, nausea, breathlessness, weakness, confusion, sleepiness, and the timing of brain fog.

Question for the visit

“Do cystatin C and creatinine agree? Could my body, medicine, thyroid, inflammation, illness, or pregnancy change either result? Would a combined eGFR, repeat, urine ACR, measured GFR, scan, or medicine review help?”
07

Sources for Cystatin C

01
National Kidney Foundation: Cystatin C

Patient explanation, venous blood procedure, use when creatinine is unclear, steroid and thyroid cautions, and aftercare

02
Mayo Clinic Laboratories: Cystatin C with eGFR

Serum specimen, method, age-specific intervals, marker physiology, adult and pediatric equations, and interpretation cautions

03
St. Louis Children's Hospital laboratory: Cystatin C

Blood specimen, no special patient preparation, pediatric intervals, and sample handling

04
KDIGO 2024 chronic kidney disease guideline

Combined marker estimates, chronicity, non-GFR errors, measured GFR, albuminuria, and kidney-health management

05
NICE: Chronic kidney disease assessment

CKD definition, repeat testing, eGFR reliability, adult staging, urine ACR, and referral context

06
NICE: Acute kidney injury

Acute change, urine output, current illness, medicine review, monitoring, and escalation

07
NIDDK: Adult eGFR equations

Current creatinine, cystatin C, and combined race-free equations, accuracy, and decision use

08
NIDDK: Child, adolescent, and young-adult eGFR equations, reviewed May 2025

Neonatal, pediatric, CKiD U25, transition-age, cystatin C, and combined equations

09
NIDDK: Clinical measurements and eGFR accuracy

Cystatin C standardization, steroid, thyroid, adiposity and inflammation effects, combined markers, and body-surface-area context

10
NIDDK: Demographics and eGFR accuracy

Age, equation variables, body composition, equation bias, removal of race, and marker comparison

11
NIDDK: Kidney function for adult drug dosing

Combined estimates near dosing cutoffs, body-size adjustment, and measured GFR when accuracy changes care

12
NIDDK: Chronic kidney disease tests

Paired blood filtration and urine albumin testing, repeat results, and CKD diagnosis

13
NIDDK: Managing chronic kidney disease

Blood pressure, diabetes, medicines, smoking, movement, sleep, and individualized food planning

14
National Kidney Foundation: Implementing race-free eGFR

When cystatin C confirms creatinine estimates, combined accuracy, and non-GFR influences on both markers

15
UK Kidney Association: Pregnancy and renal disease

Why standard eGFR and cystatin C are not valid replacements for serum creatinine in pregnancy

16
Estrella et al., JAMA, 2025

Individual-level meta-analysis of creatinine-cystatin C eGFR discordance in 860,966 outpatient and inpatient participants

17
McCoy et al., American Journal of Kidney Diseases, 2025

CRIC analysis of marker discordance, measured GFR, proposed determinants, death, and heart-failure hospitalization

18
Katz-Agranov et al., CJASN, 2024

Creatinine-cystatin C eGFR discordance in 5,574 adults aged 65 and older

19
Huang et al., JAMA Network Open, 2026

Six-year CKD cohort associating eGFR and urine protein severity with incident cognitive impairment

20
Capasso et al., Nature Reviews Nephrology, 2025

Review of cognition in CKD and the causation limits of mainly cross-sectional or associative evidence

See each claim's sources

context

A 2025 individual-level meta-analysis found eGFRcys at least 30% below eGFRcr in 11% of 821,327 outpatients and 35% of 39,639 inpatients, with associations to worse outcomes.

limitation

The 2025 discordance meta-analysis was observational and did not show that marker disagreement caused the adverse outcomes.

context

In a 2024 study of 5,574 adults aged 65 and older, eGFRcys was more than 30% lower than eGFRcr in 30%, with discordance becoming more common with age.

context

A 2026 cohort of 5,607 people with CKD associated lower filtration and more urine protein with higher incidence of selected cognitive impairments.